Biotech Company That Botched Vaccines Faces Investor Revolt

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request.

from NYT > Top Stories https://ift.tt/2VfZqER Read about Implantation bleeding quiz https://urlzs.com/fZw6K Chlamydia in men https://urlzs.com/W3NV1 https://ift.tt/2KrY6cn https://youtu.be/QFwQ6JvyPa8